UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.
NEWS
Not only Size Matters: Genetic Megastudies Draw out Distinctions between Obesity and Waist-Hip Ratio
Independent of obesity itself, WHR is a key indicator of risk of diabetes, heart disease and mortality, and appears to be regulated differently in women and men Reykjavik, ICELAND, 11 October 2010 – In two of the largest metastudies of their kind to date, scientists...
deCODE Validates Genetic Risk Factors for Osteoporosis in Chinese and Korean Populations
Study is part of broad effort to make genetic risk factors discovered in one part of the world relevant to people of other continental ancestries Reykjavik, ICELAND, 7 October 2010 – In a study published today, scientists at deCODE genetics and academic colleagues in...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.